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Purpose: For the successful treatment of thrombosed autogenous arteriovenous fistula (AVF), we designed and performed a 
hybrid surgery. Its clinical outcomes were compared with those of percutaneous mechanical thrombectomy, retrospectively. 
Methods: Forty cases of thrombosed autogenous AVFs underwent hybrid surgery, whereas 19 cases received percutaneous 
mechanical thrombectomy. Hybrid surgery consisted of surgical thrombectomy, balloon angioplasty and/or additional surgi-
cal angioplasty. Percutaneous mechanical thrombectomy included catheter-introduced thrombus aspiration, balloon angio-
plasty and/or stenting. Procedure related outcomes such as technical success rates and primary patency rates were analyzed, 
retrospectively. Results: There were no statistically significant differences between the two groups in terms of demographic 
data of the patients including age, gender, diabetes status, and frequency of antiplatelet use, as well as the characteristics of 
thrombosed autogenous AVFs such as access age, site, type, and length of time between thrombosis and AVF creation (P ＞ 
0.05). Technical success rates (92.5% vs. 68.4%, P = 0.005, respectively) and primary patency rates (85.9% vs. 36.8% at 6 
months, 81.1% vs. 26.3% at 12 months, 81.1% vs.21.1% at 18 and 24 months respectively, log-rank test, (P ＜  0.001) were sig-
nificantly higher in the hybrid surgery group. In terms of cost analysis, supply cost was not different (P = 0.065), but total cost 
was statistically lower in the hybrid surgery group (P = 0.019). Conclusion: Hybrid surgery showed better technical success 
rates and patency rates in the salvaging of thrombosed autogenous AVFs than in percutaneous mechanical thrombectomy.
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INTRODUCTION
Autogenous arteriovenous fistula (AVF) has been rec-
ommended more than other hemodialysis access using ar-
tificial graft. The cost of maintaining autogenous AVF is 
less expensive than artificial access because of lower surgi-
cal morbidity, mortality, incidence of infection and good 
patency rate [1]. However, when autogeneous AVF was 
occluded by thrombosis, the salvaging procedures for re-
vascularization didn’t show satisfactory results. The 
National Kidney Foundation Dialysis Outcomes Quality 
Initiatives suggests that choosing the method of salvage 
procedure depends on the ability of each institution [2].
To improve the technical success rates of thrombosed Jong Hee Hyun, et al.
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autogenous AVFs salvage and to prolong the patency 
rates, two treatment modalities of both surgical and endo-
vascular treatment have been combined and performed in 
the same operative setting in our institution since June 
2008. The experiences in treatment of thrombosed autoge-
nous AVFs were reviewed and the outcomes of two sal-
vage procedures of the hybrid surgery and the percuta-
neous mechanical thrombectomy were compared. 
METHODS
Study design 
Fifty nine patients with thrombosed autogenous AVF 
were included. From March 2005 to May 2008, 19 patients 
were managed with percutaneous mechanical thrombec-
tomy and from June 2008 to August 2010, 40 patients were 
managed with hybrid surgery. The medical records of con-
secutive patients with thrombosed autogenous AVFs who 
underwent hybrid surgery or percutaneous mechanical 
thrombectomy were reviewed. Among the multiple 
thrombectomy procedures in patients during the study 
period, only the first procedure was included. Arteriove-
nous fistulas with artificial graft, even composite fistulas 
including a polytetrafluroethylene graft segment, venous 
transposed AVFs and AVFs treated with pharmacological 
thrombolysis were excluded.
The radiologic image records were reviewed to identify 
the location of vascular stenosis in each patient. The pa-
tients’ demographics including types of vascular access, 
age of AVFs, length of time between thrombosis and sal-
vage procedure, operating time, technical success rates 
and procedure related complications were collected. 
Technical success rate was defined as the successful re-
storation of AVF flow with uneventful dialysis after the 
procedure. Primary patency was calculated from the date 
of the initial salvage procedure to the next subsequent ac-
cess intervention. Under the circumstance where the ma-
jority of patients were referred from other dialysis centers 
and referred back after successful treatment, patency rate 
was estimated by telephone survey and patency was con-
firmed by successful dialysis. Fistula follow-up was cen-
sored for patient death, transplant, and change of dialysis 
modality. This single center retrospective study has been 
approved by the Institutional Review Board.
Hybrid surgery
All procedures were performed under the local 
anesthesia. An approximately 2 to 3 cm transverse skin in-
cision was made over non-punctured fistulated vein. The 
vein was dissected from the surrounding tissue and con-
trolled with a vessel loop proximally and distally. A trans-
verse venotomy was made and the distal thrombus was re-
moved with forceps and/or a 4 or 5-F Fogarty balloon cath-
eter (Edwards Lifesciences LLC., Irvine, CA, USA). In cas-
es where the thrombectomy was incomplete, the remain-
ing thrombus was removed by manual squeezing the ve-
notomy opening. In patients with central vein stenosis, the 
thrombus was aspirated using a 5-F glide catheter (Teru-
mo Co., Tokyo, Japan). Afterwards, a 7-F introducer (Teru-
mo Co.) was introduced via distal fistulotomy opening 
and a fistulogram was taken to identify the etiology of the 
blood flow blockage and remnant thrombus. The prox-
imal fistulogram was taken in the same manner. If rem-
nant thrombus was found at fistulography, manual 
squeezing and passes of thrombectomy catheter were 
repeated. After thrombectomy, luminal were confirmed 
by fistulography. When stenotic lesions were identified by 
fistulography, a 0.035-inch angled guide wire M (Terumo 
Co.) was introduced and passed stenotic lesions to the cen-
tral vein distally or to the artery proximally. Systemic hep-
arinization was done (50 IU/kg) via the fistulotomy using 
5-F glide catheter into the central vein. Balloon angio-
plasty was performed to correct the stenotic lesions using 
6 to 12 mm noncompliant balloon catheters for draining 
vein and central vein, and 4 to 6 mm for juxta-anastomosis. 
If the stenotic lesions were completely corrected after bal-
loon angioplasty in the fistulogram, the venotomy was 
closed with 6.0 polypropylene sutures. Whenever balloon 
angioplasty failed, surgical angioplasty including anasto-
mosis revision, interposition or jump graft, and patch an-
gioplasty, was additionally performed. After completion 
of endovascular or surgical angioplasty, a completion fis-
tulography was taken and the restoration of blood flow 
was confirmed (Fig. 1). All procedures were performed in 
an operation unit, and fistulography was obtained using Hybrid surgery and arteriovenous fistula
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Fig. 1. Schematic diagram for the operative processes of hybrid 
surgery for thrombosed autogenous arteriovenous fistulas (AVF).
Table 1. Overall characteristics of the two study groups, hybrid surgery and percutaneous mechanical thrombectomy
Characteristic
Hybrid surgery 
(n = 40)
Percutaneous mechanical 
thrombectomy (n = 19)
P-value
Patients’ characteristics
Age (yr) 57.9 ± 17.3 61.9 ± 15.9 0.405
Sex, female 17 (42.5) 9 (47.3) 0.725
Diabetes 18 (45.0) 6 (31.6) 0.327
Anti-platelets 13 (32.5) 9 (47.4) 0.270
AVF characteristics
AVF age (mo) 53.7 ± 52.7 34.8 ± 22.6 0.157
Right/Left side (n)     3/37     0/19 0.220
AVF type 0.749
Radial-cephalic 23 (57.5) 12 (63.2)
Brachial-cephalic 16 (40.0) 7 (36.8)
Ulnar-basilic 1 (2.5) 0 (0)
Length of time between thrombosis
and salvage procedure (day) 2.3 ± 3.0 1.3 ± 0.6 0.190
Values are presented as mean ± SD or number (%).
AVF, arteriovenous fistula.
OEC 9900 Elite; C-arm fluoroscopy (GE OEC Medical 
Systems Inc., Salt Lake City, UT, USA).
Percutaneous mechanical thrombectomy
During the percutaneous mechanical thrombectomy, 
the thrombosed autogenous AVF was initially cannulated 
immediately proximal to the arterial anastomosis with 
18-gauge needle. Mechanical thrombectomy was achieved 
with a Trerotola device (Teleflex Inc., Limerick, PA, USA). 
The AVF was accessed for a second time towards the arte-
rial anastomosis. A glide wire was passed into the arterial 
circulation, and a Fogarty balloon catheter was passed 
over the wire beyond the arterial anastomosis and pulled 
back to dislodge the occluding clot. Once the thrombus 
had been cleared and blood flow re-established, a digitally 
subtracted angiogram of the fistula was performed to eval-
uate for stenotic lesions along the venous outlet track or 
central circulation. If a hemodynamically significant le-
sion was encountered, an angioplasty balloon was inflated 
at the level of the stenotic site. In two patents with central 
v e n o u s  s t e n o s i s  r e f r a c t o r y  t o  a n g i o p l a s t y ,  s t e n t s  w e r e  
deployed. Hemostasis was achieved using a modified 
purse-string suture technique. 
Statistics
Patients treated with hybrid surgery and percutaneous 
mechanical thrombectomy were compared using Student's 
t-tests for continuous variables and chi-square test for cate-
gorical variables. The patency outcomes were calculated 
using the Kaplan-Meier method and patency rates were 
compared with the log-rank test. SPSS ver. 16.0 (SPSS Inc., 
Chicago, IL, USA) was used for the statistical analysis. All 
continuous variables are expressed as means ± standard 
deviation. P ＜  0.05 was considered statistically significant.Jong Hee Hyun, et al.
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Table 2. Angiographic findings of thrombosed autogenous arteriovenous fistulas
Angiographic finding
Hybrid surgery 
(n = 40)
Percutaneous mechanical 
thrombectomy (n = 19)
P-value
No. of stenosis 2.1 ± 1.2 2.3 ± 0.9    0.487
Primary stenosis
a)    0.915
Juxta-anastomosis 17  (42.5) 7  (36.9)
Draining vein 20 (50.0) 10 (52.6)
Central vein 3 (7.5) 2 (10.5)
Artery 0 (0.0) 0 (0.0)       −
No stenosis 0 (0.0) 0 (0.0)       −
Aneurysmal change 8 (20.0) 4 (21.1)    0.925
Values are presented as mean ± SD or number (%).
a)Stenosis that was believed to be the primary cause of fistula failure.
RESULTS
Overall characteristics of patients
The clinical characteristics of the patients treated with 
hybrid surgery and those treated with percutaneous me-
chanical thrombectomy were compared in Table 1. The 
variables of patients’ age, sex, diabetes status, or fre-
quency of anti-platelets use did not significantly differ be-
tween the groups. Moreover, the other variables of the ac-
cess age, side, type, and mean duration of thrombosis were 
also not significantly different between the groups (P ＞ 
0.05). 
Angiographic findings and procedure-related out-
comes
All the thrombosed autogenous AVFs were found to 
have a stenosis that was believed to be the primary cause of 
fistula failure (Table 2). The primary lesion was at jux-
ta-anastomosis in 24 of 59 AVFs (40.7%), at draining vein in 
30 (50.8%), and at central vein in 5 (8.5%). Only 17 of 59 
AVFs (28.8%) had a single stenotic lesion, and the mean 
number of stenosis per each AVF was not statistically dif-
ferent between the two treatment groups (2.1 ± 1.2 vs. 2.3 ± 
0.9, P = 0.651, respectively).
In the group of patients treated with hybrid surgery, the 
primary lesions were treated with mainly balloon angio-
plasty followed by surgical thrombectomy. However, 11 of 
40 AVFs (27.5%) in the hybrid surgery group, required ad-
ditional surgical angioplasties, such as anastomosis re-
vision (n = 7), patching (n = 2), interposition grafting (n = 1), 
or curettage for intraluminal old fibrous thrombus (n = 1). 
In the percutaneous mechanical thrombectomy group, all 
of the lesions were treated with balloon angioplasty, with 
two patients undergoing adjunctive stent placement for 
the recoiling central venous stenosis. 
Procedure time was similar between the groups (108.1 ± 
47.9 min. vs. 115.6 ± 63.5 min., P = 0.624, respectively). 
Technical success rates were higher in the hybrid surgery 
group than that in the percutaneous mechanical throm-
bectomy group (92.5% vs. 68.4%, P = 0.005, respectively). 
The rescued AVF could be used immediately after the op-
eration or on the next day.
There were three technical failures in the hybrid surgery 
group. Two were caused by complete occlusion of central 
venous outflow, which prevented the guide wire passing 
through it. One failure was caused by tight stricture near 
the cephalic arch resistant to balloon angioplasty. In the 
percutaneous mechanical thrombectomy group, the cause 
of failure included incomplete thrombectomy; the remain-
ing thrombus was shown in the angiography (n = 4, 
66.7%), and the inability to pass a guide wire through sten-
otic lesions (n = 2, 33.3%). In either group, there were no 
procedure-related complications that required additional 
treatment. Bleedings caused by vessel tearing during bal-
loon angioplasty, were successfully controlled by balloon 
tamponade and/or external compression in both groups. 
The percutaneous mechanical thrombectomy group 
showed a tendency for longer hospital stay but was not 
statistically significant (1.0 ± 2.0 days vs. 2.3 ± 2.9 days, P = 
0.058, respectively). Hybrid surgery and arteriovenous fistula
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Table 3. Comparison of procedure-related outcomes of hybrid surgery and percutaneous mechanical thrombectomy
Procedure-related outcomes
Hybrid surgery 
(n = 40)
Percutaneous mechanical 
thrombectomy (n = 19)
P-value
Procedure time (min) 108.1 ± 47.9 115.6 ± 63.5 0.624
Technical success rate (%)     92.5     68.4 0.005
Hospital stay (day) 1.0 ± 2.0 2.3 ± 2.9 0.058
Complications, n (%)
Vessel tearing      7 (17.5)      3 (15.8) 0.870
AVF infection    0 (0.0)    0 (0.0) −
Arterial embolism    0 (0.0)    0 (0.0) −
Cost analysis
Supply costs (₩) 3.75 × 10
5 5.71 × 10
5 0.065
Total costs (₩) 1.56 × 10
6 2.03 × 10
6 0.019
AVF, arteriovenous fistula; ₩, won (Korean monetary unit).
Fig. 2. Kaplan-Meier primary patency rate curve treated with 
hybrid surgery and percutaneous mechanical thrombectomy 
describing 2-year follow-up of thrombosed autogenous arterio-
venous fistulas.
In cost analysis, the costs for the supply units were not 
different (3.75 × 10
5 won vs. 5.71 × 10
5 won, P = 0.065, re-
spectively), but total costs were statistically lower in the 
hybrid surgery group (1.56 × 10
6 won vs. 2.03 × 10
6 won, P 
= 0.019, respectively) (Table 3). 
Primary patency rate after salvage procedure
Fifty (84.7%) patients could be followed for 6 months; 42 
(71.2%) patients for 12 months; 30 (28.8%) patients for 24 
months. The mean duration follow-up after salvage was 
15.8 ± 8.1 months. The primary fistula patency rate after 
salvage was significantly better in the hybrid surgery 
group than in the percutaneous mechanical thrombec-
tomy group (log-rank test, P ＜  0.001) (Fig. 2). Primary pa-
tency of salvaged AVF by hybrid surgery was 85.9% and 
81.1% at 6 months and 12 months, respectively. No addi-
tional event was recorded until 24 months. Primary pa-
tency of salvaged AVF by percutaneous mechanical 
thrombectomy was 36.8%, 26.3% and 21.2% at 6 months, 
12 months, and 24 months, respectively.
DISCUSSION
The aim of this study is to compare the outcomes of two 
patient groups with thrombosed autogenous AVF treated 
with hybrid surgery and percutaneous mechanical throm-
bectomy.
An increasing number of patients with renal failure are 
requiring long-term dialysis for 5 to 10 years or even 
longer. If the clotted vascular access is routinely aban-
doned, there will be a large number of patients in most di-
alysis populations who will exhaust the more desirable 
upper extremity access sites and require alternate sites 
such as the leg or chest wall. In some patients, all available 
sites may eventually be used, prohibiting further hemo-
dialysis. Therefore, salvage of thrombosed vascular access 
is also important due to the limited resources of blood ves-
sels available for the creation of new access and the spar-
ing hemodialysis catheter needed during access matura-
tion [3]. 
Most clotted AVFs have one or more underlying sten-
otic lesions, a complete thrombectomy in conjunction with 
angioplasty of the stenotic lesions should be required to Jong Hee Hyun, et al.
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successfully treat the AVF thrombosis and to save the pre-
vious dialysis access site [4].
Traditionally, the treatment of thrombosed AVFs con-
sisted of surgical thrombectomy followed by local re-
vision of the access. It is often difficult to completely re-
move the thrombus adjacent to an anastomosis of the fistu-
la and an aneurysm within the fistula, which can prevent 
it from passing the thrombectomy catheter. Therefore, sur-
gical thrombectomy of autogenous AVFs is often thought 
to be a challenging and fruitless endeavor. 
Several comparative studies of surgical versus endovas-
cular treatment of thrombosed accesses have reported that 
surgery was superior to endovascular treatment in terms 
of success rate and long-term patency rate, although endo-
vascular treatment has been used worldwide because of its 
convenience [5-8]. However, clots could be retained in 
multiple areas of aneurysmal dilatation, and the major 
cause of technical failure included incomplete thrombec-
tomy after percutaneous procedures. During hybrid sur-
gery, clots, even large pieces of thrombus, contained in 
aneurysm, could be removed feasibly by manual squeeze, 
multiple passes of thrombectomy catheter and surgical 
curettage. After the procedure, luminal patency could be 
confirmed using angioplasty.
Most episodes of access thrombosis coincide with the 
presence of stenosis. It is necessary to detect its sites and to 
correct the lesions promptly for access salvage. The surgi-
cal revision of thrombosed AVFs is often considered a 
struggle for the vascular surgeon because it is difficult to 
accurately detect and completely correct stenotic lesions. 
Although Jain et al. [9] have reported improved techni-
cal success rates of percutaneous mechanical thrombec-
tomy (76.0%) for thrombosed autogenous AVFs recently, 
primary fistula patency was fairly short-lived, and the fis-
tula required repeated interventions to achieve long-term 
survival. Though the technical success rate (68.4%) and 
primary patency rate (36.8% at 6 months) of percutaneous 
mechanical trombectomy in our institution were com-
parable to other reports, more improved results were 
needed. Therefore, we have tried to develop a new salvage 
technique that is able to improve technical success rates 
and primary patency rates. Surgical revision at the time of 
thrombectomy, as directed by fistulography, has been 
demonstrated to improve patency rates [10,11]. Combined 
surgical thrombectomy with endovascular treatment for 
salvage of thromobsed autogenous AVFs have been in-
troduced and reported reasonable success rates (7 of 10, 
70%) compared to others [12]. 
To obtain the synergy effect of both surgical and endo-
vascular treatment and to improve the technical success 
rate, hybrid surgery has been used for thrombosed autog-
enous AVFs salvage in our institution since June 2008. 
Hybrid surgery is able to remove thrombus feasibly in the 
surgical fields and correct underlying causative lesions 
disclosed by the intra-operative fluoroscopy. As a con-
sequence, hybrid surgery has shown much-improved 
technical success rates (92.5%), and higher primary pa-
tency rates than percutaneous mechanical thrombectomy 
in other reports [9]. 
The most substantial contribution to a cost difference 
might have been due to significant differences in technical 
success or complication rates because the need for re-
peated procedures would likely overwhelm the moderate 
per-procedure costs, as could excess hospital stay and oth-
er costs of treatment complications. We demonstrated a 
significantly increased total cost for percutaneous me-
chanical thrombectomy as compared with hybrid surgery. 
It is difficult to explain that the cost differences reflected 
the procedure itself because significantly different techni-
cal success rates were found between the two groups. The 
major components of this cost analysis were repeated or 
additional procedures and prolonged hospital stay. 
Moreover, surgery is priced relatively low in Korea.
Hybrid surgery for treatment of thrombosed AVFs has 
several advantages. First, the thrombus could be removed 
more feasibly than percutaneous thrombectomy. Second, 
endovascular treatment could be performed in both prox-
imal and distal vessels with a single skin incision and 
fistulotomy. Third, endovascular or surgical angioplasty 
was possible by the accurate detection of the stenosis site 
by fistulogram during surgery. Lastly, this operation set-
ting permits easy conversion to surgical angioplasty. 
Our study has some limitations, which include too 
small a number of case population to reach the relevant 
conclusions from these promising results, though autoge-
nous AVF thrombosis is a relatively uncommon event than Hybrid surgery and arteriovenous fistula
thesurgery.or.kr 49
is graft thrombosis.
In conclusion, salvage procedures for thrombosed au-
togenous AVFs could be performed in an operation unit 
under the intra-operative fluoroscopy to define the cause 
of AVF thrombosis and to determine the method of appro-
priate revision. In this study, hybrid surgery showed high-
er a technical success rate and primary patency rate than 
those of percutaneous mechanical thrombectomy, thereby, 
avoiding the need for placement of a dialysis catheter.
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